跳至主要内容
临床试验/NCT04500613
NCT04500613已完成不适用

Utilization of Erector Spinae Plane Blocks in a Multimodal Analgesic Pathway for Instrumentation and Fusion of Adolescent Idiopathic Scoliosis: A Feasibility Study

Hospital for Special Surgery, New York2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
2
主要终点
Number of Patients Who Receive Bilateral, Pre-incision ESPB

研究概览

简要总结

Pediatric spinal fusion (PSF) surgery is a painful procedure that can treat adolescent idiopathic scoliosis (AIS). One technique that can potentially reduce patients' pain levels and need for opioid medication is the ultrasound-guided Erector Spinae Plane Block (ESPB). The ESP block is a technique that involves injecting an anesthetic medication into the muscles of the lower back on both sides of the spine. Previous studies have shown that ESPB application led to a reduction in opioid use, and there is one pediatric case report of ESPB use in two patients undergoing PSF. However, there is still lack of evidence that the ESPB technique is feasible and effective in the pediatric patient population.

The present study is designed to be the first randomized controlled trial to evaluate the role of ESPB in pediatric spinal fusion surgery and the role of ESPB within an enhanced recovery pathway.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
10 Years 至 19 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Age 10-19 years old
  • Patients undergoing multilevel posterior spinal instrumentation and fusion
  • Undergoing surgery for correction of adolescent idiopathic scoliosis
  • Patients under the care of participating surgeons
  • English Speaking

排除标准

  • Patients younger than 10 years old or older than 19 years old
  • Neuromuscular scoliosis
  • Patient under the care of non-participating surgeon performing the procedure
  • History of chronic opioid therapy (longer than 4 weeks) to treat back pain attributed to scoliosis tolerance, as defined by Centers for Disease Control (CDC) criteria (more than 60 oral morphine equivalents (OME) daily for over 2 weeks)
  • Chronic pain conditions necessitating neuromodulating medications (gabapentin, pregabalin)
  • Allergy, intolerance, or contraindication to any protocol component/study medication/technique
  • Patient or parent refusal
  • Non-english speaking

结局指标

主要结局

Number of Patients Who Receive Bilateral, Pre-incision ESPB

时间窗: through study completion, an average of 1 year

number who receive the intervention and complete all assessments

次要结局

  • Rate of Recruitment(through study completion, an average of 1 year)
  • Attrition(through study completion, an average of 1 year)
  • Blinding Assessment(24 hours after surgery)
  • Number of Participants Unable to Receive ESPB Block.(Holding area, Post-Anesthesia Care Unit (PACU) (hour 0), hour 8, 12, and 24 hours after surgery)
  • Incidence of Intra- and Postoperative Complications Attributed to ESPB(During surgery, PACU (hour 0), hour 8, 12, and 24 hours after surgery)
  • Pain Scores at Rest and Movement(PACU (Post Anesthesia Care Unit, hour 0), hour 8, 12, and 24 hours after surgery, and at hospital discharge (an average of 4 days))
  • Total Opioid Consumption(0-24 hours after surgery (OME within 24 hrs))
  • Time to First Opioid Use(Up to 24 hours after surgery)
  • Patient/Parent Satisfaction With Pain Management(At hospital discharge (an average of 4 days))
  • Opioid Related Side Effects(24 hours after surgery)

研究者

发起方
Hospital for Special Surgery, New York
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验